T. Rowe Price Associates
GNPX icon

T. Rowe Price Associates’s Genprex GNPX Stock Holding History

T. Rowe Price Associates’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– -$12K – 2908
2023
Q1 		– Sell
-1
Closed -$56.4K – 2875
2022
Q4 		$37K Sell
1
-1
-50% -$56.5K ﹤0.01% 2843
2022
Q3 		$96K Hold
2
– – ﹤0.01% 2737
2022
Q2 		$112K Hold
2
– – ﹤0.01% 2736
2022
Q1 		$174K Hold
2
– – ﹤0.01% 2744
2021
Q4 		$101K Buy
2
+1
+100% +$83.4K ﹤0.01% 2871
2021
Q3 		$125K Hold
1
– – ﹤0.01% 2802
2021
Q2 		$126K Hold
1
– – ﹤0.01% 2812
2021
Q1 		$160K Hold
1
– – ﹤0.01% 2734
2020
Q4 		$169K Hold
1
– – ﹤0.01% 2578
2020
Q3 		$166K Hold
1
– – ﹤0.01% 2459
2020
Q2 		$103K Buy
+1
New +$122K ﹤0.01% 2427
2020
Q1 		– Hold
0
– – – 2472

Other funds holding GNPX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
CC
Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
VCP
Verus Capital Partners Scottsdale, Arizona $1.46B AUM 27.29% 1-Year Est. Return

T. Rowe Price Associates's GNPX Position: Q2 2023 in Review

T. Rowe Price Associates held its Genprex (GNPX) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2908.

T. Rowe Price Associates first reported a position in GNPX in Q2 2020 and has held it in 11 quarters since. The position peaked at $174K in Q1 2022. 16 funds tracked by Wall St. Rank hold GNPX as of Q2 2023.

  • T. Rowe Price Associates held 0 shares of Genprex worth $0 as of Q2 2023.
  • T. Rowe Price Associates left its Genprex share count unchanged in Q2 2023.
  • Genprex made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2023, its #2908 holding.
  • T. Rowe Price Associates first reported a position in Genprex in Q2 2020 and has held it in 11 quarters since.
  • T. Rowe Price Associates's Genprex position peaked at $174K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Genprex as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.